Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2013 1
2015 2
2016 3
2017 6
2018 4
2019 2
2020 5
2021 4
2022 5
2023 7
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Effects of Dupilumab on Mucus Plugging and Ventilation Defects in Patients with Moderate-to-Severe Asthma: A Randomized, Double-Blind, Placebo-Controlled Trial.
Svenningsen S, Kjarsgaard M, Haider E, Venegas C, Konyer N, Friedlander Y, Nasir N, Boylan C, Kirby M, Nair P. Svenningsen S, et al. Among authors: kjarsgaard m. Am J Respir Crit Care Med. 2023 Nov 1;208(9):995-997. doi: 10.1164/rccm.202306-1102LE. Am J Respir Crit Care Med. 2023. PMID: 37603097 Clinical Trial. No abstract available.
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.
Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Lau KS, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Nair P, Ho T, Balakrishnan N, Nazy I, Bowdish DME, Svenningsen S, Carlsten C, Mukherjee M. Son K, et al. Among authors: kjarsgaard m. Eur Respir J. 2023 Jan 12;61(1):2200970. doi: 10.1183/13993003.00970-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36137590 Free PMC article.
Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma.
Svenningsen S, Kjarsgaard M, Zhang K, Serajeddini H, Garrido CV, Bhalla A, Radford K, Huang C, Ho T, Ragunayakam N, Thakar A, Radadia N, Mukherjee M, Nair P. Svenningsen S, et al. Among authors: kjarsgaard m. Allergy. 2024 Feb;79(2):509-513. doi: 10.1111/all.15901. Epub 2023 Sep 26. Allergy. 2024. PMID: 37750593 No abstract available.
Airway autoantibodies are determinants of asthma severity.
Salter B, Zhao N, Son K, Tan NS, Dvorkin-Gheva A, Radford K, LaVigne N, Huang C, Kjarsgaard M, Li QZ, Tselios K, Lim HF, Khalidi N, Nair P, Mukherjee M. Salter B, et al. Among authors: kjarsgaard m. Eur Respir J. 2022 Dec 1;60(6):2200442. doi: 10.1183/13993003.00442-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 35777765 Free article.
A case series of dual biologics therapy for severe asthma.
Serajeddini H, Venegas Garrido C, Bhalla A, Kjarsgaard M, Huang C, LaVigne N, Radford K, Zhang K, Ho T, Svenningsen S, Mukherjee M, Nair P. Serajeddini H, et al. Among authors: kjarsgaard m. J Allergy Clin Immunol Pract. 2023 Jan;11(1):335-340.e2. doi: 10.1016/j.jaip.2022.09.036. Epub 2022 Oct 7. J Allergy Clin Immunol Pract. 2023. PMID: 36210053 No abstract available.
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology.
Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P. Bhalla A, et al. Among authors: kjarsgaard m. Allergy. 2021 Mar;76(3):957-958. doi: 10.1111/all.14534. Epub 2020 Aug 24. Allergy. 2021. PMID: 32767400 Free PMC article. No abstract available.
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive.
Ju X, Son K, Jamil R, Culgin S, Salter B, Miyasaki K, Fard NE, Xiao M, Patel Z, Zhang K, Cowbrough B, Kjarsgaard M, Radford K, Dvorkin-Gheva A, Richards CD, Cox G, Chagla Z, Smieja M, Tunks M, Alhazzani W, Bowdish DME, Perri D, Nair PK, Sehmi R, Mukherjee M. Ju X, et al. Among authors: kjarsgaard m. Allergy Asthma Clin Immunol. 2023 Jul 4;19(1):58. doi: 10.1186/s13223-023-00810-6. Allergy Asthma Clin Immunol. 2023. PMID: 37403168 Free PMC article. No abstract available.
41 results